Abbott says market overestimating sales hit from new diabetes drugs
Abbott Laboratories said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs,
Abbott Laboratories said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs,
The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised
Nestle Health Science will buy the rights to Seres Therapeutics' Vowst, the companies said on Thursday, gaining full access to the first-ever pill alternative to fecal
Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S.
Savara said on Wednesday its experimental therapy met the main goal of a late-stage trial by improving a measure of lung function in patients with a rare disease that causes
Cassava Sciences will form a committee to evaluatenew probes by U.S. regulators and investigate two senior employees, it said on Monday, days after a
Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
Your subscription has been successfully upgraded!